Larvol Delta - Biomea-Fusion-Announces-First-Patient-Dosed-in-Phase-I-Study-of-BMF650-a-NextGeneration-Oral-GLP1-Receptor-Agonist

BMF-650 - Biomea Fusion

https://www.globenewswire.com/news-release/2025/10/27/3174503/0/en/Biomea-Fusion-Announces-First-Patient-Dosed-in-Phase-I-Study-of-BMF-650-a-Next-Generation-Oral-GLP-1-Receptor-Agonist.html

Oct 27, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next